Soligenix to Present at The Microcap Conference
PRINCETON, N.J., Jan. 25, 2024 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Company will deliver a corporate presentation at The Microcap Conference. The conference will be held January 30 and 31, and February 1, 2024 at Caesars Atlantic City Hotel & Casino in Atlantic City, N.J. For more information about The Microcap Conference, please refer to the conference website at https://themicrocapconference.com.
Related news for (SNGX)
- 24/7 Market News Snapshot 04 September, 2025 – Soligenix, Inc. Common Stock (NASDAQ:SNGX)
- Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses
- Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference
- Today’s Top Performers: MoBot’s Market Review 08/18/25 11:00 AM
- Breaking News: MoBot’s Latest Update as of 08/18/25 10:00 AM